Healthcare provider profile · identity verified

Timothy R Howe, M.D.

Internal Medicine · BRUNSWICK, ME · NPI 1083776371

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	700	192
Lisinopril	Lisinopril	508	137
Losartan Potassium	Losartan Potassium	470	134
Amlodipine Besylate	Amlodipine Besylate	389	117
Levothyroxine Sodium	Levothyroxine Sodium	267	72
Eliquis	Apixaban	249	58
Metoprolol Succinate	Metoprolol Succinate	233	66
Omeprazole	Omeprazole	229	66
Sertraline Hcl	Sertraline Hcl	227	63
Jardiance	Empagliflozin	190	48
Metformin Hcl	Metformin Hcl	175	49
Telmisartan	Telmisartan	158	46
Hydrochlorothiazide	Hydrochlorothiazide	141	51
Metoprolol Tartrate	Metoprolol Tartrate	132	34
Famotidine	Famotidine	128	40
Simvastatin	Simvastatin	123	34
Rosuvastatin Calcium	Rosuvastatin Calcium	121	37
Albuterol Sulfate Hfa	Albuterol Sulfate	120	53
Tamsulosin Hcl	Tamsulosin Hcl	118	42
Furosemide	Furosemide	106	37
Carvedilol	Carvedilol	104	35
Trazodone Hcl	Trazodone Hcl	97	32
Duloxetine Hcl	Duloxetine Hcl	85	25
Gabapentin	Gabapentin	81	24
Prednisone	Prednisone	79	33
Rybelsus	Semaglutide	73	19
Pantoprazole Sodium	Pantoprazole Sodium	68	23
Spironolactone	Spironolactone	66	24
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	65	20
Escitalopram Oxalate	Escitalopram Oxalate	62	17
Synthroid	Levothyroxine Sodium	61	13
Ozempic	Semaglutide	56	11
Atenolol	Atenolol	49	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	49	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	12
Allopurinol	Allopurinol	46	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	46	19
Alendronate Sodium	Alendronate Sodium	44	12
Chlorthalidone	Chlorthalidone	44	14
Metformin Hcl Er	Metformin Hcl	43	16
Donepezil Hcl	Donepezil Hcl	42	suppressed
Finasteride	Finasteride	42	12
Nitroglycerin	Nitroglycerin	42	30
Amitriptyline Hcl	Amitriptyline Hcl	41	suppressed
Potassium Chloride	Potassium Chloride	40	14
Clopidogrel	Clopidogrel Bisulfate	39	13
Hydrocortisone	Hydrocortisone	38	22
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Warfarin Sodium	Warfarin Sodium	37	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	34	28
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Bupropion Xl	Bupropion Hcl	33	11
Citalopram Hbr	Citalopram Hydrobromide	32	12
Xarelto	Rivaroxaban	32	suppressed
Farxiga	Dapagliflozin Propanediol	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	13
Torsemide	Torsemide	30	11
Bisoprolol Fumarate	Bisoprolol Fumarate	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Lorazepam	Lorazepam	29	15
Levetiracetam	Levetiracetam	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	14
Diazepam	Diazepam	27	suppressed
Trulicity	Dulaglutide	27	suppressed
Amoxicillin	Amoxicillin	26	15
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Labetalol Hcl	Labetalol Hcl	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	14
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Glipizide Er	Glipizide	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Ondansetron Odt	Ondansetron	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	11
Lamotrigine	Lamotrigine	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Arnuity Ellipta	Fluticasone Furoate	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Clonazepam	Clonazepam	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Liothyronine Sodium	Liothyronine Sodium	18	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	17	suppressed
Nystatin	Nystatin	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Valsartan	Valsartan	17	suppressed
Alprazolam	Alprazolam	16	12
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Cefadroxil	Cefadroxil	16	13
Celecoxib	Celecoxib	16	suppressed
Digoxin	Digoxin	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Risperidone	Risperidone	16	suppressed
Tramadol Hcl	Tramadol Hcl	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	15	15
Carbamazepine Er	Carbamazepine	14	suppressed
Jantoven	Warfarin Sodium	14	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Travoprost	Travoprost	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Fluconazole	Fluconazole	13	12
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Lithium Carbonate	Lithium Carbonate	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Multaq	Dronedarone Hcl	13	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Montelukast Sodium	Montelukast Sodium	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error